Medical Care
Global Allergic Asthma Therapeutics Market Research Report 2024
- Jan 20, 24
- ID: 12742
- Pages: 97
- Figures: 183
- Views: 37
The global Allergic Asthma Therapeutics market was valued at US$ 6655.8 million in 2023 and is anticipated to reach US$ 8092.3 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
Report Scope
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergic Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergic Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Segment by Type
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergic Asthma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
Report Scope
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergic Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergic Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Segment by Type
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergic Asthma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ASM-8
1.2.3 AXP-1275
1.2.4 Beta-escin
1.2.5 CHF-6001
1.2.6 CSL-311
1.2.7 Dalazatide
1.2.8 Others
1.3 Market by Application
1.3.1 Global Allergic Asthma Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergic Asthma Therapeutics Market Perspective (2019-2030)
2.2 Allergic Asthma Therapeutics Growth Trends by Region
2.2.1 Global Allergic Asthma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Allergic Asthma Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Allergic Asthma Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Allergic Asthma Therapeutics Market Dynamics
2.3.1 Allergic Asthma Therapeutics Industry Trends
2.3.2 Allergic Asthma Therapeutics Market Drivers
2.3.3 Allergic Asthma Therapeutics Market Challenges
2.3.4 Allergic Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergic Asthma Therapeutics Players by Revenue
3.1.1 Global Top Allergic Asthma Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allergic Asthma Therapeutics Revenue
3.4 Global Allergic Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Asthma Therapeutics Revenue in 2023
3.5 Allergic Asthma Therapeutics Key Players Head office and Area Served
3.6 Key Players Allergic Asthma Therapeutics Product Solution and Service
3.7 Date of Enter into Allergic Asthma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergic Asthma Therapeutics Breakdown Data by Type
4.1 Global Allergic Asthma Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2025-2030)
5 Allergic Asthma Therapeutics Breakdown Data by Application
5.1 Global Allergic Asthma Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Allergic Asthma Therapeutics Market Size (2019-2030)
6.2 North America Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Allergic Asthma Therapeutics Market Size by Country (2019-2024)
6.4 North America Allergic Asthma Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergic Asthma Therapeutics Market Size (2019-2030)
7.2 Europe Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Allergic Asthma Therapeutics Market Size by Country (2019-2024)
7.4 Europe Allergic Asthma Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergic Asthma Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Allergic Asthma Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergic Asthma Therapeutics Market Size (2019-2030)
9.2 Latin America Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Allergic Asthma Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Allergic Asthma Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergic Asthma Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aslan Pharmaceuticals Pte. Ltd.
11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Detail
11.1.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview
11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Introduction
11.1.4 Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
11.2 Axikin Pharmaceuticals, Inc.
11.2.1 Axikin Pharmaceuticals, Inc. Company Detail
11.2.2 Axikin Pharmaceuticals, Inc. Business Overview
11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.2.4 Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.2.5 Axikin Pharmaceuticals, Inc. Recent Development
11.3 Baxalta Incorporated
11.3.1 Baxalta Incorporated Company Detail
11.3.2 Baxalta Incorporated Business Overview
11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Introduction
11.3.4 Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.3.5 Baxalta Incorporated Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Detail
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Circassia Pharmaceuticals Plc
11.5.1 Circassia Pharmaceuticals Plc Company Detail
11.5.2 Circassia Pharmaceuticals Plc Business Overview
11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Introduction
11.5.4 Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.5.5 Circassia Pharmaceuticals Plc Recent Development
11.6 CSL Limited
11.6.1 CSL Limited Company Detail
11.6.2 CSL Limited Business Overview
11.6.3 CSL Limited Allergic Asthma Therapeutics Introduction
11.6.4 CSL Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.6.5 CSL Limited Recent Development
11.7 Fountain Biopharma Inc.
11.7.1 Fountain Biopharma Inc. Company Detail
11.7.2 Fountain Biopharma Inc. Business Overview
11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Introduction
11.7.4 Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.7.5 Fountain Biopharma Inc. Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Detail
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Hydra Biosciences, Inc.
11.9.1 Hydra Biosciences, Inc. Company Detail
11.9.2 Hydra Biosciences, Inc. Business Overview
11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Introduction
11.9.4 Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.9.5 Hydra Biosciences, Inc. Recent Development
11.10 Infinity Pharmaceuticals, Inc.
11.10.1 Infinity Pharmaceuticals, Inc. Company Detail
11.10.2 Infinity Pharmaceuticals, Inc. Business Overview
11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.10.4 Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.10.5 Infinity Pharmaceuticals, Inc. Recent Development
11.11 Kineta, Inc.
11.11.1 Kineta, Inc. Company Detail
11.11.2 Kineta, Inc. Business Overview
11.11.3 Kineta, Inc. Allergic Asthma Therapeutics Introduction
11.11.4 Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.11.5 Kineta, Inc. Recent Development
11.12 Mabtech Limited
11.12.1 Mabtech Limited Company Detail
11.12.2 Mabtech Limited Business Overview
11.12.3 Mabtech Limited Allergic Asthma Therapeutics Introduction
11.12.4 Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.12.5 Mabtech Limited Recent Development
11.13 Marinomed Biotechnologie GmbH
11.13.1 Marinomed Biotechnologie GmbH Company Detail
11.13.2 Marinomed Biotechnologie GmbH Business Overview
11.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Introduction
11.13.4 Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.13.5 Marinomed Biotechnologie GmbH Recent Development
11.14 Mycenax Biotech Inc.
11.14.1 Mycenax Biotech Inc. Company Detail
11.14.2 Mycenax Biotech Inc. Business Overview
11.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Introduction
11.14.4 Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.14.5 Mycenax Biotech Inc. Recent Development
11.15 NeoPharm Co., Ltd.
11.15.1 NeoPharm Co., Ltd. Company Detail
11.15.2 NeoPharm Co., Ltd. Business Overview
11.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Introduction
11.15.4 NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.15.5 NeoPharm Co., Ltd. Recent Development
11.16 Oxagen Limited
11.16.1 Oxagen Limited Company Detail
11.16.2 Oxagen Limited Business Overview
11.16.3 Oxagen Limited Allergic Asthma Therapeutics Introduction
11.16.4 Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.16.5 Oxagen Limited Recent Development
11.17 Panacea Biotec Limited
11.17.1 Panacea Biotec Limited Company Detail
11.17.2 Panacea Biotec Limited Business Overview
11.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Introduction
11.17.4 Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.17.5 Panacea Biotec Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ASM-8
1.2.3 AXP-1275
1.2.4 Beta-escin
1.2.5 CHF-6001
1.2.6 CSL-311
1.2.7 Dalazatide
1.2.8 Others
1.3 Market by Application
1.3.1 Global Allergic Asthma Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergic Asthma Therapeutics Market Perspective (2019-2030)
2.2 Allergic Asthma Therapeutics Growth Trends by Region
2.2.1 Global Allergic Asthma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Allergic Asthma Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Allergic Asthma Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Allergic Asthma Therapeutics Market Dynamics
2.3.1 Allergic Asthma Therapeutics Industry Trends
2.3.2 Allergic Asthma Therapeutics Market Drivers
2.3.3 Allergic Asthma Therapeutics Market Challenges
2.3.4 Allergic Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergic Asthma Therapeutics Players by Revenue
3.1.1 Global Top Allergic Asthma Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allergic Asthma Therapeutics Revenue
3.4 Global Allergic Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Asthma Therapeutics Revenue in 2023
3.5 Allergic Asthma Therapeutics Key Players Head office and Area Served
3.6 Key Players Allergic Asthma Therapeutics Product Solution and Service
3.7 Date of Enter into Allergic Asthma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergic Asthma Therapeutics Breakdown Data by Type
4.1 Global Allergic Asthma Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2025-2030)
5 Allergic Asthma Therapeutics Breakdown Data by Application
5.1 Global Allergic Asthma Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Allergic Asthma Therapeutics Market Size (2019-2030)
6.2 North America Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Allergic Asthma Therapeutics Market Size by Country (2019-2024)
6.4 North America Allergic Asthma Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergic Asthma Therapeutics Market Size (2019-2030)
7.2 Europe Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Allergic Asthma Therapeutics Market Size by Country (2019-2024)
7.4 Europe Allergic Asthma Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergic Asthma Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Allergic Asthma Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergic Asthma Therapeutics Market Size (2019-2030)
9.2 Latin America Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Allergic Asthma Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Allergic Asthma Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergic Asthma Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aslan Pharmaceuticals Pte. Ltd.
11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Detail
11.1.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview
11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Introduction
11.1.4 Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
11.2 Axikin Pharmaceuticals, Inc.
11.2.1 Axikin Pharmaceuticals, Inc. Company Detail
11.2.2 Axikin Pharmaceuticals, Inc. Business Overview
11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.2.4 Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.2.5 Axikin Pharmaceuticals, Inc. Recent Development
11.3 Baxalta Incorporated
11.3.1 Baxalta Incorporated Company Detail
11.3.2 Baxalta Incorporated Business Overview
11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Introduction
11.3.4 Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.3.5 Baxalta Incorporated Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Detail
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Circassia Pharmaceuticals Plc
11.5.1 Circassia Pharmaceuticals Plc Company Detail
11.5.2 Circassia Pharmaceuticals Plc Business Overview
11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Introduction
11.5.4 Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.5.5 Circassia Pharmaceuticals Plc Recent Development
11.6 CSL Limited
11.6.1 CSL Limited Company Detail
11.6.2 CSL Limited Business Overview
11.6.3 CSL Limited Allergic Asthma Therapeutics Introduction
11.6.4 CSL Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.6.5 CSL Limited Recent Development
11.7 Fountain Biopharma Inc.
11.7.1 Fountain Biopharma Inc. Company Detail
11.7.2 Fountain Biopharma Inc. Business Overview
11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Introduction
11.7.4 Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.7.5 Fountain Biopharma Inc. Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Detail
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Hydra Biosciences, Inc.
11.9.1 Hydra Biosciences, Inc. Company Detail
11.9.2 Hydra Biosciences, Inc. Business Overview
11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Introduction
11.9.4 Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.9.5 Hydra Biosciences, Inc. Recent Development
11.10 Infinity Pharmaceuticals, Inc.
11.10.1 Infinity Pharmaceuticals, Inc. Company Detail
11.10.2 Infinity Pharmaceuticals, Inc. Business Overview
11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.10.4 Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.10.5 Infinity Pharmaceuticals, Inc. Recent Development
11.11 Kineta, Inc.
11.11.1 Kineta, Inc. Company Detail
11.11.2 Kineta, Inc. Business Overview
11.11.3 Kineta, Inc. Allergic Asthma Therapeutics Introduction
11.11.4 Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.11.5 Kineta, Inc. Recent Development
11.12 Mabtech Limited
11.12.1 Mabtech Limited Company Detail
11.12.2 Mabtech Limited Business Overview
11.12.3 Mabtech Limited Allergic Asthma Therapeutics Introduction
11.12.4 Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.12.5 Mabtech Limited Recent Development
11.13 Marinomed Biotechnologie GmbH
11.13.1 Marinomed Biotechnologie GmbH Company Detail
11.13.2 Marinomed Biotechnologie GmbH Business Overview
11.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Introduction
11.13.4 Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.13.5 Marinomed Biotechnologie GmbH Recent Development
11.14 Mycenax Biotech Inc.
11.14.1 Mycenax Biotech Inc. Company Detail
11.14.2 Mycenax Biotech Inc. Business Overview
11.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Introduction
11.14.4 Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.14.5 Mycenax Biotech Inc. Recent Development
11.15 NeoPharm Co., Ltd.
11.15.1 NeoPharm Co., Ltd. Company Detail
11.15.2 NeoPharm Co., Ltd. Business Overview
11.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Introduction
11.15.4 NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.15.5 NeoPharm Co., Ltd. Recent Development
11.16 Oxagen Limited
11.16.1 Oxagen Limited Company Detail
11.16.2 Oxagen Limited Business Overview
11.16.3 Oxagen Limited Allergic Asthma Therapeutics Introduction
11.16.4 Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.16.5 Oxagen Limited Recent Development
11.17 Panacea Biotec Limited
11.17.1 Panacea Biotec Limited Company Detail
11.17.2 Panacea Biotec Limited Business Overview
11.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Introduction
11.17.4 Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.17.5 Panacea Biotec Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Allergic Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ASM-8
Table 3. Key Players of AXP-1275
Table 4. Key Players of Beta-escin
Table 5. Key Players of CHF-6001
Table 6. Key Players of CSL-311
Table 7. Key Players of Dalazatide
Table 8. Key Players of Others
Table 9. Global Allergic Asthma Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Allergic Asthma Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Allergic Asthma Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Allergic Asthma Therapeutics Market Share by Region (2019-2024)
Table 13. Global Allergic Asthma Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Allergic Asthma Therapeutics Market Share by Region (2025-2030)
Table 15. Allergic Asthma Therapeutics Market Trends
Table 16. Allergic Asthma Therapeutics Market Drivers
Table 17. Allergic Asthma Therapeutics Market Challenges
Table 18. Allergic Asthma Therapeutics Market Restraints
Table 19. Global Allergic Asthma Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Allergic Asthma Therapeutics Market Share by Players (2019-2024)
Table 21. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
Table 22. Ranking of Global Top Allergic Asthma Therapeutics Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Allergic Asthma Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Allergic Asthma Therapeutics Product Solution and Service
Table 26. Date of Enter into Allergic Asthma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Allergic Asthma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2019-2024)
Table 30. Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2025-2030)
Table 32. Global Allergic Asthma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2019-2024)
Table 34. Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2025-2030)
Table 36. North America Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Allergic Asthma Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 51. Aslan Pharmaceuticals Pte. Ltd. Company Detail
Table 52. Aslan Pharmaceuticals Pte. Ltd. Business Overview
Table 53. Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Product
Table 54. Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Aslan Pharmaceuticals Pte. Ltd. Recent Development
Table 56. Axikin Pharmaceuticals, Inc. Company Detail
Table 57. Axikin Pharmaceuticals, Inc. Business Overview
Table 58. Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
Table 59. Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Axikin Pharmaceuticals, Inc. Recent Development
Table 61. Baxalta Incorporated Company Detail
Table 62. Baxalta Incorporated Business Overview
Table 63. Baxalta Incorporated Allergic Asthma Therapeutics Product
Table 64. Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Baxalta Incorporated Recent Development
Table 66. Chiesi Farmaceutici SpA Company Detail
Table 67. Chiesi Farmaceutici SpA Business Overview
Table 68. Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Product
Table 69. Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Chiesi Farmaceutici SpA Recent Development
Table 71. Circassia Pharmaceuticals Plc Company Detail
Table 72. Circassia Pharmaceuticals Plc Business Overview
Table 73. Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Product
Table 74. Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Circassia Pharmaceuticals Plc Recent Development
Table 76. CSL Limited Company Detail
Table 77. CSL Limited Business Overview
Table 78. CSL Limited Allergic Asthma Therapeutics Product
Table 79. CSL Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 80. CSL Limited Recent Development
Table 81. Fountain Biopharma Inc. Company Detail
Table 82. Fountain Biopharma Inc. Business Overview
Table 83. Fountain Biopharma Inc. Allergic Asthma Therapeutics Product
Table 84. Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Fountain Biopharma Inc. Recent Development
Table 86. GlaxoSmithKline Plc Company Detail
Table 87. GlaxoSmithKline Plc Business Overview
Table 88. GlaxoSmithKline Plc Allergic Asthma Therapeutics Product
Table 89. GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 90. GlaxoSmithKline Plc Recent Development
Table 91. Hydra Biosciences, Inc. Company Detail
Table 92. Hydra Biosciences, Inc. Business Overview
Table 93. Hydra Biosciences, Inc. Allergic Asthma Therapeutics Product
Table 94. Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 95. Hydra Biosciences, Inc. Recent Development
Table 96. Infinity Pharmaceuticals, Inc. Company Detail
Table 97. Infinity Pharmaceuticals, Inc. Business Overview
Table 98. Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
Table 99. Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 100. Infinity Pharmaceuticals, Inc. Recent Development
Table 101. Kineta, Inc. Company Detail
Table 102. Kineta, Inc. Business Overview
Table 103. Kineta, Inc. Allergic Asthma Therapeutics Product
Table 104. Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Kineta, Inc. Recent Development
Table 106. Mabtech Limited Company Detail
Table 107. Mabtech Limited Business Overview
Table 108. Mabtech Limited Allergic Asthma Therapeutics Product
Table 109. Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Mabtech Limited Recent Development
Table 111. Marinomed Biotechnologie GmbH Company Detail
Table 112. Marinomed Biotechnologie GmbH Business Overview
Table 113. Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Product
Table 114. Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 115. Marinomed Biotechnologie GmbH Recent Development
Table 116. Mycenax Biotech Inc. Company Detail
Table 117. Mycenax Biotech Inc. Business Overview
Table 118. Mycenax Biotech Inc. Allergic Asthma Therapeutics Product
Table 119. Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Mycenax Biotech Inc. Recent Development
Table 121. NeoPharm Co., Ltd. Company Detail
Table 122. NeoPharm Co., Ltd. Business Overview
Table 123. NeoPharm Co., Ltd. Allergic Asthma Therapeutics Product
Table 124. NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 125. NeoPharm Co., Ltd. Recent Development
Table 126. Oxagen Limited Company Detail
Table 127. Oxagen Limited Business Overview
Table 128. Oxagen Limited Allergic Asthma Therapeutics Product
Table 129. Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 130. Oxagen Limited Recent Development
Table 131. Panacea Biotec Limited Company Detail
Table 132. Panacea Biotec Limited Business Overview
Table 133. Panacea Biotec Limited Allergic Asthma Therapeutics Product
Table 134. Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 135. Panacea Biotec Limited Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allergic Asthma Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Allergic Asthma Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. ASM-8 Features
Figure 4. AXP-1275 Features
Figure 5. Beta-escin Features
Figure 6. CHF-6001 Features
Figure 7. CSL-311 Features
Figure 8. Dalazatide Features
Figure 9. Others Features
Figure 10. Global Allergic Asthma Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Allergic Asthma Therapeutics Market Share by Application: 2023 VS 2030
Figure 12. Clinic Case Studies
Figure 13. Research Center Case Studies
Figure 14. Hospital Case Studies
Figure 15. Others Case Studies
Figure 16. Allergic Asthma Therapeutics Report Years Considered
Figure 17. Global Allergic Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Allergic Asthma Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Allergic Asthma Therapeutics Market Share by Region: 2023 VS 2030
Figure 20. Global Allergic Asthma Therapeutics Market Share by Players in 2023
Figure 21. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Allergic Asthma Therapeutics Revenue in 2023
Figure 23. North America Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 25. United States Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 29. Germany Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Allergic Asthma Therapeutics Market Share by Region (2019-2030)
Figure 37. China Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 45. Mexico Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 49. Turkey Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Aslan Pharmaceuticals Pte. Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 52. Axikin Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 53. Baxalta Incorporated Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 54. Chiesi Farmaceutici SpA Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 55. Circassia Pharmaceuticals Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 56. CSL Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 57. Fountain Biopharma Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 59. Hydra Biosciences, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 60. Infinity Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 61. Kineta, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 62. Mabtech Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 63. Marinomed Biotechnologie GmbH Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 64. Mycenax Biotech Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 65. NeoPharm Co., Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 66. Oxagen Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 67. Panacea Biotec Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Allergic Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ASM-8
Table 3. Key Players of AXP-1275
Table 4. Key Players of Beta-escin
Table 5. Key Players of CHF-6001
Table 6. Key Players of CSL-311
Table 7. Key Players of Dalazatide
Table 8. Key Players of Others
Table 9. Global Allergic Asthma Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Allergic Asthma Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Allergic Asthma Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Allergic Asthma Therapeutics Market Share by Region (2019-2024)
Table 13. Global Allergic Asthma Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Allergic Asthma Therapeutics Market Share by Region (2025-2030)
Table 15. Allergic Asthma Therapeutics Market Trends
Table 16. Allergic Asthma Therapeutics Market Drivers
Table 17. Allergic Asthma Therapeutics Market Challenges
Table 18. Allergic Asthma Therapeutics Market Restraints
Table 19. Global Allergic Asthma Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Allergic Asthma Therapeutics Market Share by Players (2019-2024)
Table 21. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
Table 22. Ranking of Global Top Allergic Asthma Therapeutics Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Allergic Asthma Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Allergic Asthma Therapeutics Product Solution and Service
Table 26. Date of Enter into Allergic Asthma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Allergic Asthma Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2019-2024)
Table 30. Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2025-2030)
Table 32. Global Allergic Asthma Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2019-2024)
Table 34. Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2025-2030)
Table 36. North America Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Allergic Asthma Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 51. Aslan Pharmaceuticals Pte. Ltd. Company Detail
Table 52. Aslan Pharmaceuticals Pte. Ltd. Business Overview
Table 53. Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Product
Table 54. Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Aslan Pharmaceuticals Pte. Ltd. Recent Development
Table 56. Axikin Pharmaceuticals, Inc. Company Detail
Table 57. Axikin Pharmaceuticals, Inc. Business Overview
Table 58. Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
Table 59. Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Axikin Pharmaceuticals, Inc. Recent Development
Table 61. Baxalta Incorporated Company Detail
Table 62. Baxalta Incorporated Business Overview
Table 63. Baxalta Incorporated Allergic Asthma Therapeutics Product
Table 64. Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Baxalta Incorporated Recent Development
Table 66. Chiesi Farmaceutici SpA Company Detail
Table 67. Chiesi Farmaceutici SpA Business Overview
Table 68. Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Product
Table 69. Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Chiesi Farmaceutici SpA Recent Development
Table 71. Circassia Pharmaceuticals Plc Company Detail
Table 72. Circassia Pharmaceuticals Plc Business Overview
Table 73. Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Product
Table 74. Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Circassia Pharmaceuticals Plc Recent Development
Table 76. CSL Limited Company Detail
Table 77. CSL Limited Business Overview
Table 78. CSL Limited Allergic Asthma Therapeutics Product
Table 79. CSL Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 80. CSL Limited Recent Development
Table 81. Fountain Biopharma Inc. Company Detail
Table 82. Fountain Biopharma Inc. Business Overview
Table 83. Fountain Biopharma Inc. Allergic Asthma Therapeutics Product
Table 84. Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 85. Fountain Biopharma Inc. Recent Development
Table 86. GlaxoSmithKline Plc Company Detail
Table 87. GlaxoSmithKline Plc Business Overview
Table 88. GlaxoSmithKline Plc Allergic Asthma Therapeutics Product
Table 89. GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 90. GlaxoSmithKline Plc Recent Development
Table 91. Hydra Biosciences, Inc. Company Detail
Table 92. Hydra Biosciences, Inc. Business Overview
Table 93. Hydra Biosciences, Inc. Allergic Asthma Therapeutics Product
Table 94. Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 95. Hydra Biosciences, Inc. Recent Development
Table 96. Infinity Pharmaceuticals, Inc. Company Detail
Table 97. Infinity Pharmaceuticals, Inc. Business Overview
Table 98. Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
Table 99. Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 100. Infinity Pharmaceuticals, Inc. Recent Development
Table 101. Kineta, Inc. Company Detail
Table 102. Kineta, Inc. Business Overview
Table 103. Kineta, Inc. Allergic Asthma Therapeutics Product
Table 104. Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Kineta, Inc. Recent Development
Table 106. Mabtech Limited Company Detail
Table 107. Mabtech Limited Business Overview
Table 108. Mabtech Limited Allergic Asthma Therapeutics Product
Table 109. Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 110. Mabtech Limited Recent Development
Table 111. Marinomed Biotechnologie GmbH Company Detail
Table 112. Marinomed Biotechnologie GmbH Business Overview
Table 113. Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Product
Table 114. Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 115. Marinomed Biotechnologie GmbH Recent Development
Table 116. Mycenax Biotech Inc. Company Detail
Table 117. Mycenax Biotech Inc. Business Overview
Table 118. Mycenax Biotech Inc. Allergic Asthma Therapeutics Product
Table 119. Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Mycenax Biotech Inc. Recent Development
Table 121. NeoPharm Co., Ltd. Company Detail
Table 122. NeoPharm Co., Ltd. Business Overview
Table 123. NeoPharm Co., Ltd. Allergic Asthma Therapeutics Product
Table 124. NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 125. NeoPharm Co., Ltd. Recent Development
Table 126. Oxagen Limited Company Detail
Table 127. Oxagen Limited Business Overview
Table 128. Oxagen Limited Allergic Asthma Therapeutics Product
Table 129. Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 130. Oxagen Limited Recent Development
Table 131. Panacea Biotec Limited Company Detail
Table 132. Panacea Biotec Limited Business Overview
Table 133. Panacea Biotec Limited Allergic Asthma Therapeutics Product
Table 134. Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024) & (US$ Million)
Table 135. Panacea Biotec Limited Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allergic Asthma Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Allergic Asthma Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. ASM-8 Features
Figure 4. AXP-1275 Features
Figure 5. Beta-escin Features
Figure 6. CHF-6001 Features
Figure 7. CSL-311 Features
Figure 8. Dalazatide Features
Figure 9. Others Features
Figure 10. Global Allergic Asthma Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Allergic Asthma Therapeutics Market Share by Application: 2023 VS 2030
Figure 12. Clinic Case Studies
Figure 13. Research Center Case Studies
Figure 14. Hospital Case Studies
Figure 15. Others Case Studies
Figure 16. Allergic Asthma Therapeutics Report Years Considered
Figure 17. Global Allergic Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Allergic Asthma Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Allergic Asthma Therapeutics Market Share by Region: 2023 VS 2030
Figure 20. Global Allergic Asthma Therapeutics Market Share by Players in 2023
Figure 21. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Allergic Asthma Therapeutics Revenue in 2023
Figure 23. North America Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 25. United States Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 29. Germany Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Allergic Asthma Therapeutics Market Share by Region (2019-2030)
Figure 37. China Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 45. Mexico Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Allergic Asthma Therapeutics Market Share by Country (2019-2030)
Figure 49. Turkey Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Allergic Asthma Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Aslan Pharmaceuticals Pte. Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 52. Axikin Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 53. Baxalta Incorporated Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 54. Chiesi Farmaceutici SpA Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 55. Circassia Pharmaceuticals Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 56. CSL Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 57. Fountain Biopharma Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 59. Hydra Biosciences, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 60. Infinity Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 61. Kineta, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 62. Mabtech Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 63. Marinomed Biotechnologie GmbH Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 64. Mycenax Biotech Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 65. NeoPharm Co., Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 66. Oxagen Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 67. Panacea Biotec Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232